119 related articles for article (PubMed ID: 38030063)
41. Impact of an integrated classifier using biomarkers, clinical and imaging factors on clinical decisions making for lung nodules.
Kheir F; Uribe JP; Cedeno J; Munera G; Patel H; Abdelghani R; Matta A; Benzaquen S; Villalobos R; Majid A
J Thorac Dis; 2023 Jul; 15(7):3557-3567. PubMed ID: 37559655
[TBL] [Abstract][Full Text] [Related]
42. Predicting Malignancy Risk of Screen-Detected Lung Nodules-Mean Diameter or Volume.
Tammemagi M; Ritchie AJ; Atkar-Khattra S; Dougherty B; Sanghera C; Mayo JR; Yuan R; Manos D; McWilliams AM; Schmidt H; Gingras M; Pasian S; Stewart L; Tsai S; Seely JM; Burrowes P; Bhatia R; Haider EA; Boylan C; Jacobs C; van Ginneken B; Tsao MS; Lam S;
J Thorac Oncol; 2019 Feb; 14(2):203-211. PubMed ID: 30368011
[TBL] [Abstract][Full Text] [Related]
43. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation.
Tanner NT; Porter A; Gould MK; Li XJ; Vachani A; Silvestri GA
Chest; 2017 Aug; 152(2):263-270. PubMed ID: 28115167
[TBL] [Abstract][Full Text] [Related]
44. Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer.
Ferguson JS; Van Wert R; Choi Y; Rosenbluth MJ; Smith KP; Huang J; Spira A
BMC Pulm Med; 2016 May; 16(1):66. PubMed ID: 27184093
[TBL] [Abstract][Full Text] [Related]
45. Comparison of prediction models with radiological semantic features and radiomics in lung cancer diagnosis of the pulmonary nodules: a case-control study.
Wu W; Pierce LA; Zhang Y; Pipavath SNJ; Randolph TW; Lastwika KJ; Lampe PD; Houghton AM; Liu H; Xia L; Kinahan PE
Eur Radiol; 2019 Nov; 29(11):6100-6108. PubMed ID: 31115618
[TBL] [Abstract][Full Text] [Related]
46. Radiomics analysis of pulmonary nodules in low-dose CT for early detection of lung cancer.
Choi W; Oh JH; Riyahi S; Liu CJ; Jiang F; Chen W; White C; Rimner A; Mechalakos JG; Deasy JO; Lu W
Med Phys; 2018 Apr; 45(4):1537-1549. PubMed ID: 29457229
[TBL] [Abstract][Full Text] [Related]
47. Benign-malignant classification of pulmonary nodules by low-dose spiral computerized tomography and clinical data with machine learning in opportunistic screening.
Zheng Y; Dong J; Yang X; Shuai P; Li Y; Li H; Dong S; Gong Y; Liu M; Zeng Q
Cancer Med; 2023 Jun; 12(11):12050-12064. PubMed ID: 37248730
[TBL] [Abstract][Full Text] [Related]
48. Clinical Utility of a Bronchial Genomic Classifier in Patients With Suspected Lung Cancer.
Vachani A; Whitney DH; Parsons EC; Lenburg M; Ferguson JS; Silvestri GA; Spira A
Chest; 2016 Jul; 150(1):210-8. PubMed ID: 26896702
[TBL] [Abstract][Full Text] [Related]
49. Differences in VA and Non-VA Pulmonary Nodules: All Evaluations Are not Created Equal.
New ML; Hirsch EA; Feser WJ; Malkoski SP; Garg K; Miller YE; Baron AE
Clin Lung Cancer; 2023 Jul; 24(5):407-414. PubMed ID: 37012147
[TBL] [Abstract][Full Text] [Related]
50. EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation.
Duarte A; Corbett M; Melton H; Harden M; Palmer S; Soares M; Simmonds M
Health Technol Assess; 2022 Dec; 26(49):1-184. PubMed ID: 36534989
[TBL] [Abstract][Full Text] [Related]
51. 68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer.
Walker R; Deppen S; Smith G; Shi C; Lehman J; Clanton J; Moore B; Burns R; Grogan EL; Massion PP
PLoS One; 2017; 12(2):e0171301. PubMed ID: 28182730
[TBL] [Abstract][Full Text] [Related]
52. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R
Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848
[TBL] [Abstract][Full Text] [Related]
53. Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling.
Hanas JS; Peyton MD; Lerner MR; Lightfoot SA; Deb SJ; Hanas RJ; Vu NT; Kupiec TC; Stowell DE; Brackett DJ; Dubinett SM; Hocker JR
Cancer Invest; 2014 May; 32(4):136-43. PubMed ID: 24579933
[TBL] [Abstract][Full Text] [Related]
54. [Advances and Clinical Application of Malignant Probability Prediction Models for
Solitary Pulmonary Nodule].
Wang Z; Zhao J; Wang M
Zhongguo Fei Ai Za Zhi; 2021 Sep; 24(9):660-667. PubMed ID: 34455736
[TBL] [Abstract][Full Text] [Related]
55. Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules.
Patel KN; Angell TE; Babiarz J; Barth NM; Blevins T; Duh QY; Ghossein RA; Harrell RM; Huang J; Kennedy GC; Kim SY; Kloos RT; LiVolsi VA; Randolph GW; Sadow PM; Shanik MH; Sosa JA; Traweek ST; Walsh PS; Whitney D; Yeh MW; Ladenson PW
JAMA Surg; 2018 Sep; 153(9):817-824. PubMed ID: 29799911
[TBL] [Abstract][Full Text] [Related]
56. Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study.
Tanner NT; Aggarwal J; Gould MK; Kearney P; Diette G; Vachani A; Fang KC; Silvestri GA
Chest; 2015 Dec; 148(6):1405-1414. PubMed ID: 26087071
[TBL] [Abstract][Full Text] [Related]
57. A decision tree model to distinguish between benign and malignant pulmonary nodules on CT scans.
Ma XB; Xu QL; Li N; Wang LN; Li HC; Jiang SJ
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5692-5699. PubMed ID: 37401307
[TBL] [Abstract][Full Text] [Related]
58. Machine learning approach for distinguishing malignant and benign lung nodules utilizing standardized perinodular parenchymal features from CT.
Uthoff J; Stephens MJ; Newell JD; Hoffman EA; Larson J; Koehn N; De Stefano FA; Lusk CM; Wenzlaff AS; Watza D; Neslund-Dudas C; Carr LL; Lynch DA; Schwartz AG; Sieren JC
Med Phys; 2019 Jul; 46(7):3207-3216. PubMed ID: 31087332
[TBL] [Abstract][Full Text] [Related]
59. Comparison of ultra-low dose chest CT scanning protocols for the detection of pulmonary nodules: a phantom study.
Milanese G; Silva M; Frauenfelder T; Eberhard M; Sabia F; Martini C; Marchianò A; Prokop M; Sverzellati N; Pastorino U
Tumori; 2019 Oct; 105(5):394-403. PubMed ID: 31041885
[TBL] [Abstract][Full Text] [Related]
60. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
